About Nixi
Nixi is a Healthcare company based in India founded in 2020 by Sanjeev Kumar. It manufactures liquid and dry injections for pharmaceutical contract services. It operates on a B2B and Contract Manufacturing model. The company has 29 employees. Its Indian entity Nixi Laboratories Private Limited reported revenue of ₹80.22 Cr. Nixi offers products and services including Liquid Injections and Dry Injections. Its focus areas include Pharmaceutical Manufacturing, Injectables and Liquid and Dry Injections. Its competitors include Gland Pharma and Nitin Lifesciences.
Company details
Nixi Laboratories Pvt. Ltd. specializes in producing liquid and dry injections as a pharmaceutical contract manufacturer. They operate a state-of-the-art facility in Himachal Pradesh, with an additional office in Mumbai, and provide third-party manufacturing with a focus on quality and compliance. The company employs a skilled team and delivers affordable, effective products to clients across India, adhering to international standards like WHO and GMP.
- Headquarters India
- Employees 29
- Founders Sanjeev Kumar
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website nixilaboratories.com
- Social LinkedIn
- Legal Name Nixi Laboratories Private Limited
- Date of Incorporation 08 Mar, 2016
- Jurisdiction Nahan, Himachal Pradesh, India
- Annual Revenue₹80.22 Cr
FY 2025 · +60% YoY
- Net Profit₹1.93 Cr
FY 2025 · 2% margin
- EBITDA₹7.40 Cr
FY 2025 · 9% margin
- Employee Count29
Associated legal entities of Nixi
Nixi operates through Nixi Laboratories Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Nixi Laboratories Private Limited CIN U24100HP2016PTC001167 | Active | 08 Mar 2016 | Nahan, Himachal Pradesh | ₹80.2 Cr | 29 | 4 | View details |
Products & Services of Nixi
Nixi offers a comprehensive portfolio of products and services, including Liquid Injections and Dry Injections.
Manufactured for medical treatments and third-party supply
Produced for pharmaceutical use in various applications
Board of directors of Nixi Laboratories Private Limited (Nixi)
Nixi Laboratories Private Limited is the primary company behind Nixi. The board of Nixi Laboratories Private Limited currently have 4 directors; the longest-serving is Harmanpreet Singh, appointed in 2016. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Harmanpreet Singh DIN 06786919 | Director | 08 Mar 2016 | 10 yrs 7 mo | Nixi Laboratories Private Limited |
| Paresh Shantilal Bagadia DIN 01636125 | Director | 01 Mar 2021 | 5 yrs 7 mo | Nixi Laboratories Private Limited |
| Aditya Gupta DIN 00694184 | Director | 01 Mar 2021 | 5 yrs 7 mo | Nixi Laboratories Private Limited |
| Gurudev Singh Raina DIN 11026160 | Whole-time director | 29 Mar 2025 | 1 yr 7 mo | Nixi Laboratories Private Limited |
People of Nixi
1 people are tracked at Nixi (1 in leadership); the tracked headcount is 29.
| Name | Role | Group |
|---|---|---|
| Founder, Managing Director | Leadership |
Complete people profiles for Nixi
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Nixi
Figures of Nixi Laboratories Private Limited, the primary company behind Nixi, for FY 2025. Revenue was ₹80.22 Cr (+60% year on year). Net profit was ₹1.93 Cr (2% margin). EBITDA was ₹7.40 Cr (9% margin). Revenue has grown at a compounded annual rate of +8% over three years and +139% over five years.
- ₹80.22 CrRevenue · FY 2025 · +60% YoY
- ₹1.93 CrNet profit · 2% margin
- ₹7.40 CrEBITDA · 9% margin
- ₹9.90 CrPaid-up capital
- 29Employees (provident fund records)
- +8%Revenue CAGR, 3 years
- +139%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Nixi Laboratories Private Limited are on its company page.
Detailed financial statements for Nixi
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Nixi
Nixi has 2 listed competitors in our database. They include Gland Pharma and Nitin Lifesciences.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| glandpharma.com | 1978 | Hyderabad, India | 4,319 | Generic injectable drugs are manufactured across therapeutic segments. | ||
| nitinlifesciences.com | 1994 | Karnal, India | 56 | CMO of small volume parenteral injectables |
Detailed competitors of Nixi
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Nixi
The website of Nixi (nixilaboratories.com) receives about 5K visits a month.
- Monthly visits5K
▲ 258.1% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Nixi
Nixi was founded in 2020.
Nixi is headquartered in India.
Nixi has 29 employees.
The primary company behind Nixi, Nixi Laboratories Private Limited, reported revenue of ₹80.22 Cr for FY 2025, up 60% year on year.
Nixi Laboratories Pvt. Ltd. specializes in producing liquid and dry injections as a pharmaceutical contract manufacturer. They operate a state-of-the-art facility in Himachal Pradesh, with an additional office in Mumbai, and provide third-party manufacturing with a focus on quality and compliance. The company employs a skilled team and delivers affordable, effective products to clients across India, adhering to international standards like WHO and GMP.
Nixi's top competitors include Gland Pharma and Nitin Lifesciences.
Nixi offers Liquid Injections and Dry Injections.
Nixi operates through Nixi Laboratories Private Limited.
The legal entities of Nixi currently have 4 directors, including Harmanpreet Singh, Paresh Shantilal Bagadia, Aditya Gupta and others.